Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNUM.L Regulatory News (NUM)

  • There is currently no data for NUM

Trading Update

27 Sep 2019 07:00

RNS Number : 8779N
Numis Corporation PLC
27 September 2019
 

Numis Corporation Plc ("Numis")

Trading Update

 

Embargoed for release 7.00 am, 27 September 2019

 

 

Friday 27 September 2019 at 7.00am: Numis Corporation Plc ("Numis") is today issuing a trading update in respect of the year ending 30 September 2019.

 

The political uncertainty and challenging market conditions which impacted our first half performance have persisted throughout the second half of the financial year. UK equity capital markets volumes and trading activity in UK equities have both declined significantly compared to the prior year. Against this unfavourable market backdrop, Numis expects to report a reasonable second half performance delivering revenues in line with the first half and slightly behind the comparable period. This will result in reported revenues for the full year showing a mid to high teens percentage decline compared to the prior year, and a somewhat greater fall in profit given the operational gearing inherent in the business.

 

Investment Banking revenues have been impacted by lower deal volumes, particularly at the larger end of the transaction size range. Challenging market conditions often present opportunities to expand our corporate client base and we continue to add high quality companies to our list. We currently have 217 corporate clients, up from 210 at the start of the year.

 

Whilst public market deal flow has been subdued we have made good progress growing our private markets presence, including raising $460m for Swedish fintech business Klarna at a valuation of $5.5bn. The increase in revenue attributable to private markets transactions has partially offset the significant decline in UK listed capital markets activities. We will continue to target the revenue opportunities generated by the growing allocation of institutional capital to private markets activity.

 

Equities has reported an improved second half performance predominantly due to a better trading book performance. Execution revenues and research payments have remained consistent with the levels achieved in the first half, which suggests we have gained market share against a market which contracted over the period.

 

Our headcount is broadly flat compared to the prior year-end as we responded to the prevailing market uncertainty by focusing on efficiency and productivity gains, however, our longer term growth plans and strategy remain unchanged. We are pleased to confirm we have entered into a lease for new office space given the upcoming expiry of our current lease. We intend to relocate during the second half of FY21 and expect the new office will give rise to an increase of approximately £3m to our ongoing property costs, including the impact of IFRS 16, commencing FY21.

 

Numis will announce preliminary results for the year ending 30 September 2019 on Wednesday 4 December 2019.

 

 

Alex Ham and Ross Mitchinson, Co-Chief Executive Officers said:

 

"2019 was a challenging year, characterised by market share gains but depressed activity levels across both Investment Banking and Equities. The office move is indicative of our long term ambitions for the business. Over the past 13 years in our existing office we have doubled headcount, doubled the corporate client list and seen the average market capitalisation of that client base increase by a multiple of five. Whilst prevailing market conditions are difficult, we have a very strong balance sheet and exceptional people serving an enviable list of retained corporate clients and high quality institutions. We are well positioned to continue to capture greater market share and we will continue to focus on executing our long term strategy to build a more diversified investment banking business."

 

 

27 September 2019

 

END

 

 

Contacts

Numis

Alex Ham and Ross Mitchinson, Co-CEOs 020 7260 1245

Andrew Holloway, CFO 020 7260 1266

 

Brunswick (Public Relations Adviser):

Nick Cosgrove 020 7404 5959

Simone Selzer 020 7404 5959

 

Grant Thornton UK LLP (Nominated Adviser):

Philip Secrett 020 7728 2578

Jen Clarke 020 7865 2411Harrison J Clarke 020 7184 4384

 

 

Notes for Editors

 

Numis is a leading independent investment banking group offering a full range of research, execution, corporate broking and advisory services to companies and their investors.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUNVRRKSAKUUR
Date   Source Headline
1st Jun 20204:07 pmRNSTransaction in Own Shares and Total Voting Rights
29th May 20207:00 amRNSTransaction in Own Shares and Total Voting Rights
20th May 20209:55 amRNSTransaction in Own Shares and Total Voting Rights
18th May 20201:48 pmRNSTransaction in Own Shares and Total Voting Rights
12th May 20207:00 amRNSHalf-year Report
6th May 20207:00 amRNSRelease date of half year results
27th Apr 20204:42 pmRNSSecond Price Monitoring Extn
27th Apr 20204:35 pmRNSPrice Monitoring Extension
30th Mar 202011:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Mar 20207:00 amRNSTrading Update
23rd Mar 20205:23 pmRNSTransaction in Own Shares and Total Voting Rights
17th Mar 20204:54 pmRNSTransaction in Own Shares and Total Voting Rights
16th Mar 20202:15 pmRNSTransaction in Own Shares and Total Voting Rights
11th Mar 20209:14 amRNSTransaction in Own Shares and Total Voting Rights
6th Mar 20202:12 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20205:40 pmRNSTransaction in Own Shares and Total Voting Rights
3rd Mar 20205:57 pmRNSTransaction in Own Shares and Total Voting Rights
17th Feb 202011:21 amRNSTransaction in Own Shares and Total Voting Rights
13th Feb 20205:15 pmRNSTransaction in Own Shares and Total Voting Rights
4th Feb 20201:05 pmRNSResult of AGM
4th Feb 20207:00 amRNSAGM Trading Update
3rd Feb 20202:09 pmRNSTR-1: Notification of major holdings
3rd Feb 202012:44 pmRNSTransaction in Own Shares and Total Voting Rights
31st Jan 202010:16 amRNSTR-1: Notification of major holdings
30th Jan 20204:36 pmRNSTransaction in Own Shares and Total Voting Rights
28th Jan 20203:07 pmRNSTransaction in Own Shares and Total Voting Rights
24th Jan 20204:25 pmRNSTransaction in Own Shares and Total Voting Rights
23rd Jan 202010:16 amRNSTransaction in Own Shares and Total Voting Rights
21st Jan 202011:00 amRNSDirector Dealing
20th Jan 20205:46 pmRNSTransaction in Own Shares and Total Voting Rights
16th Jan 20204:16 pmRNSTransaction in Own Shares and Total Voting Rights
2nd Jan 20202:03 pmRNSTR-1: Notification of major holdings
2nd Jan 20207:00 amRNSAnnual Report and Annual General Meeting Notice
30th Dec 201911:00 amRNSTR-1: Notification of major holdings
19th Dec 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Dec 20192:41 pmRNSDirectors' Dealing
13th Dec 20192:14 pmRNSTR-1: Notification of major holdings
10th Dec 20196:00 pmRNSTransfer of Shares from Treasury to EBT and TVR
5th Dec 20194:29 pmRNSDirector dealing
4th Dec 20197:00 amRNSPreliminary Results for the year ended 30 Sep 2019
2nd Dec 20195:27 pmRNSTransaction in Own Shares and Total Voting Rights
29th Nov 201910:08 amRNSTransaction in Own Shares and Total Voting Rights
25th Nov 20193:39 pmRNSTransaction in Own Shares and Total Voting Rights
21st Nov 201911:00 amRNSTransaction in Own Shares and Total Voting Rights
15th Nov 201911:00 amRNSTR-1: Notification of major holdings
15th Nov 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Nov 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Oct 20193:35 pmRNSTransaction in Own Shares and Total Voting Rights
25th Oct 20197:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 201912:02 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.